Treatment Resistant Depression
By Amy Banks
If you have depression but your medication
is not working or the side effects are
intolerable; you may have what is known as
treatment resistant depression.
Author: Amy Banks
Inside Magstim
By Amy Banks
Take a look inside Magstim. At Magstim, we believe in developing cost-effective, innovative TMS solutions, enabling ground breaking neuroscience research & TMS Therapy. Dr. M. Polson gives us a look inside Magstim and the story of TMS therapy. Neuromodulation Research Magstim TMS Therapy The Brains Behind TMS™ Versatile TMS Solutions Trusted Worldwide Enhanced Clinic Support … Continued
Setting up a TMS Clinic
By Amy Banks
We spoke to our UK Sales Manager Andrew Dixon, who works with clinics to help them get established, to get his top tips for setting up a TMS clinic:
NHS clinical trial could pave the way for new depression treatment
By Amy Banks
How we treat depression in the future may be set to change as the NHS begins an unprecedented two year study using transcranial magnetic stimulation (TMS).
What Happens during a TMS treatment?
By Amy Banks
It’s one of the most common questions we get asked. Patients want to know what will happen before, during and after a TMS treatment. Your TMS provider will talk you through what to expect in detail before you start but here is our quick step-by-step guide on what a typical therapy session is like.
How Does Horizon TMS Therapy Compare?
By Amy Banks
Looking to buy a TMS therapy system? Find out how the Horizon TMS therapy compares to other systems with this infographic.
Introducing Horizon® Performance
By Amy Banks
Magstim, the pioneer of a revolutionary non-invasive treatment for depression, has announced that its latest TMS therapy product, the Horizon Performance, has achieved CE mark regulatory approval and 510(k) clearance from the FDA.
Magstim receive a contract from the Veteran Administration
By Amy Banks
Morrisville, NC, October 17, 2017 — Magstim, a pioneer in the study and development of Transcranial Magnetic Stimulation (TMS), has received a contract from the Veterans Administration to help treat Major Depressive Disorder (MDD) in Veterans who have failed to achieve satisfactory improvement from prior antidepressant medication.
Magstim Group, Inc. appoints Lothar Krinke as New CEO.
By Amy Banks
Magstim Group, Inc., the pioneer in trans-cranial magnetic stimulation and intraoperative nerve monitoring, today announced that it has appointed Lothar Krinke, Ph.D., as Chief Executive Officer effective immediately. Dr. Krinke will serve on the Board of Directors of Magstim. He will be responsible for Magstim and Technomed.